:

What is the new drug for dementia? Donanemab and Lecanemab Explained

Affecting over 6 million Americans, Alzheimer’s is the most common form of dementia and has long lacked effective disease-modifying treatments. A recent paradigm shift has introduced new therapeutic options, providing a modern answer to the question: **What is the new drug for dementia?** The latest developments offer new hope for those in the early stages of the disease.